Home/Filings/4/0001493152-22-030909
4//SEC Filing

Nomikos George 4

Accession 0001493152-22-030909

CIK 0001535955other

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 11:57 AM ET

Size

5.5 KB

Accession

0001493152-22-030909

Insider Transaction Report

Form 4
Period: 2022-11-01
Nomikos George
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-11-01$0.41/sh+125,000$50,750125,000 total
    Exercise: $0.41From: 2023-11-01Exp: 2032-11-01Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of November 1, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years.

Documents

1 file

Issuer

Lipocine Inc.

CIK 0001535955

Entity typeother

Related Parties

1
  • filerCIK 0001953799

Filing Metadata

Form type
4
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 11:57 AM ET
Size
5.5 KB